Key participants include Bachem, PolyPeptide Group, CordenPharma, Lonza, and WuXi STA, which collectively account for an estimated 80% of the outsourced semaglutide and tirzepatide API CDMO market, owing to their established commercial manufacturing infrastructure and significant investments in GLP-1 peptide capacity expansion
Solaas et al
Positive and negative antibody-based immunoassay
Why choose Impact Health in Oxford
Most peptides degrade rapidly in the body, but BPC-157 remains active long enough to exert therapeutic effects
Helen Knight, the director of medicines evaluation at Nice, added: Type 2 diabetes is becoming more prevalent in society, so new treatment options are needed to help people with it to control their blood-glucose levels